Police Seize Over 4000 e-Cigarette Pods in Drug Raid

Regulations by 2FIRSTS.ai

Jun.20.2024

Police Seize Over 4000 e-Cigarette Pods in Drug Raid

New Taipei City police seized over 4000 e-cigarette pods in a drug raid based on a tip, leading to an arrest.

According to a report from Focustaiwan on June 20th, the police in New Taipei City, Taiwan seized over 4,000 e-cigarette replacement pods in a drug raid last week.

According to a press release from the agency, this drug bust was carried out based on an anonymous tip, which reported that a resident in Sanchong District had stockpiled a large number of e-cigarette pods at home. At 5 pm on June 13, the police raided the residence of a 24-year-old man surnamed Dong and seized thousands of replacement pods in various flavors.

According to the police, the man purchased these pods online and sold them on social media platforms, which was his main source of income. In a raid, authorities seized a total of 4,189 pods, estimated to have a market value of 1 million New Taiwan Dollars (approximately $30,868 USD).

In the testing, it was found that these pods contained "Methoxy Ma Huang Tang", a synthetic stimulant classified as a Class III drug in Taiwan, China.

Currently, the man has been arrested and transferred to the New Taipei District Prosecutors Office in Taiwan for investigation on suspicion of violating Taiwan's Harm Prevention Act.

The "Tobacco Hazards Prevention Act" in Taiwan, China prohibits the production, sale, import, supply, and advertising of "imitation tobacco products," including electronic nicotine and non-nicotine delivery systems such as e-cigarettes, pods, and vape pens.

References:

[1] Sanchong police seize over 4,000 vape pods during drug bust

Also Read:

[1] Court Proceeding on Alleged Smuggling of Over 95,000 E-cigarettes by Former Taipei Customs

[2] Enforcement Authorities Penalize 579 Cases with 33.43 million yuan

[3] Rise of E-cigarette Use among Youth in Taiwan, with Growth Rate of 50%

[4] Illegal E-cigarette Factory Discovered in Taiwan's New Taipei

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Alan Zhao: What Altria’s on! PLUS Authorization Really Signals About FDA PMTA Enforcement

In this in-depth commentary for 2Firsts, Alan Zhao examines what Altria’s on! PLUS authorization really signals about FDA PMTA enforcement. Beyond the headline approval, FDA’s language, process design and product choices offer rare insight into how nicotine pouch regulation is taking shape—and what it means for industry compliance, in one of the earliest expert reads of the decision.

Regulations

Dec.20 by 2Firsts Perspectives

South Korea’s Tobacco Law Amendment to Include Synthetic Nicotine, Projected to Add Up to $340 Million in Local Tax Revenue

Following the National Assembly’s approval of amendments to the Tobacco Business Act on September 22, redefining tobacco to include synthetic nicotine, the Korea Institute of Local Finance (KILF) estimates that local governments could gain between $37 million and $340 million in additional tax revenue in 2025 from tobacco consumption and local education taxes.

Nov.19 by 2FIRSTS.ai

Product | Pouchless Oral Nicotine NAKD Nicotine Pods Launch with “Garlic-Clove” Shape and Structural Design Drawing Attention

NAKD nicotine pods have been launched overseas with a pouchless solid-pellet design, featuring a “garlic clove–like” appearance that is smaller than traditional nicotine pouches. Made from compostable materials and positioned around instant nicotine release, the product is developed by Norwegian brand Den Norske Snusfabrikken and is already available in several European markets.

Nov.18 by 2FIRSTS.ai

Philip Morris Korea: IQOS ILUMA i “SELETTI” Limited Edition Sells Out in One Week; Prime Model Sells Out on Launch Day